跳至主要内容
临床试验/ACTRN12621000184875
ACTRN12621000184875进行中(未招募)未知

Mass screening for atrial fibrillation in the over-75s using handheld devices integrated with a central monitoring service: A pilot study of feasibility and preliminary efficacy

Westmead Applied Research Centre, University of Sydney0 个研究点目标入组 200 人开始时间: 2021年2月22日最近更新:
适应症

试验速览

阶段
未知
状态
进行中(未招募)
发起方
入组人数
200

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Diagnosis
盲法
Open (masking not used)

入排标准

年龄范围
75 Years 至 o limit(—)
性别
All

入选标准

  • 1) Community-dwelling people aged 75 or older
  • 2) Have a smartphone that is able to operate AliveCor Kardia system
  • 3) Be able to understand instructions in English

排除标准

  • 1) Having documented diagnosis of AF
  • 2) Having an implantable pacemaker or defibrillator, or both
  • 3) Dementia
  • 4) Inability to provide informed consent
  • 5) Medical illness with anticipated life expectancy < 3 months

研究者

发起方
Westmead Applied Research Centre, University of Sydney

相似试验